{"id":807679,"date":"2025-02-03T07:08:55","date_gmt":"2025-02-03T12:08:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/"},"modified":"2025-02-03T07:08:55","modified_gmt":"2025-02-03T12:08:55","slug":"lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/","title":{"rendered":"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CHASKA, Minn., Feb.  03, 2025  (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical, Inc. (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2frafHgUIOvtJ4Swgc_tsqji8YlnOkp7c57qq6ftzN94FPnrMjffY1rpdLUcdUoSazBKevD9O_6mEGmC43XDSo2Zll-PHpInn0ot4hf1v9M=\" rel=\"nofollow\" target=\"_blank\">LFCR<\/a>) (\u201cLifecore\u201d), a fully integrated contract development and manufacturing organization (\u201cCDMO\u201d), today announced that the company will participate at the 2025 BIO CEO &amp; Investor Conference. The conference will take place February 10-11, 2025, in New York, NY.<\/p>\n<p>Details regarding Lifecore\u2019s participation are as follows:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>2025 BIO CEO &amp; Investor Conference<br \/><\/strong>Details: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings<br \/>Conference Dates: February 10-11, 2025<br \/>Location: New York, NY<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Lifecore Biomedical <\/strong>\n      <\/p>\n<p align=\"justify\">Lifecore Biomedical, Inc. (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2frafHgUIOvtJ4Swgc_tst6jjjdYaZgzCn47A8QSC5E377fITi8hpfMyaleGN_BNgBrraZETlvBq1qc-oph_omOPpcBBMDbG2C-FKw-UQ74=\" rel=\"nofollow\" target=\"_blank\">LFCR<\/a>) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore\u2019s website at <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Be-3CMpONoF6PpdS7sAXdQjwuUgCAn5qWPjkT8h2I43_W24xBnr_BzI209hJm9Hli-TEqliSABX0pxP6cvEVDQ==\" rel=\"nofollow\" target=\"_blank\">www.lifecore.com<\/a><\/u>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDVkZDVhMDYtY2E5ZS00YzI3LTliYjYtYTU5NzZjNzUzNzU1LTEwMTkzMjk=\/tiny\/Lifecore-Biomedical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Lifecore Biomedical, Inc. Contact Information:\r\n\r\nVida Strategic Partners\r\nStephanie Diaz (Investors)\r\n415-675-7401\r\nsdiaz@vidasp.com\u00a0\r\n\r\nTim Brons (Media)\r\n415-675-7402\r\ntbrons@vidasp.com\u00a0\r\n\r\nRyan D. Lake (CFO)\r\nLifecore Biomedical\r\n952-368-6244\r\nryan.lake@lifecore.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical, Inc. (NASDAQ: LFCR) (\u201cLifecore\u201d), a fully integrated contract development and manufacturing organization (\u201cCDMO\u201d), today announced that the company will participate at the 2025 BIO CEO &amp; Investor Conference. The conference will take place February 10-11, 2025, in New York, NY. Details regarding Lifecore\u2019s participation are as follows: 2025 BIO CEO &amp; Investor ConferenceDetails: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetingsConference Dates: February 10-11, 2025Location: New York, NY About Lifecore Biomedical Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-807679","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical, Inc. (NASDAQ: LFCR) (\u201cLifecore\u201d), a fully integrated contract development and manufacturing organization (\u201cCDMO\u201d), today announced that the company will participate at the 2025 BIO CEO &amp; Investor Conference. The conference will take place February 10-11, 2025, in New York, NY. Details regarding Lifecore\u2019s participation are as follows: 2025 BIO CEO &amp; Investor ConferenceDetails: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetingsConference Dates: February 10-11, 2025Location: New York, NY About Lifecore Biomedical Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile &hellip; Continue reading &quot;Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-03T12:08:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference\",\"datePublished\":\"2025-02-03T12:08:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/\"},\"wordCount\":189,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/\",\"name\":\"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=\",\"datePublished\":\"2025-02-03T12:08:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference - Market Newsdesk","og_description":"CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Lifecore Biomedical, Inc. (NASDAQ: LFCR) (\u201cLifecore\u201d), a fully integrated contract development and manufacturing organization (\u201cCDMO\u201d), today announced that the company will participate at the 2025 BIO CEO &amp; Investor Conference. The conference will take place February 10-11, 2025, in New York, NY. Details regarding Lifecore\u2019s participation are as follows: 2025 BIO CEO &amp; Investor ConferenceDetails: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetingsConference Dates: February 10-11, 2025Location: New York, NY About Lifecore Biomedical Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile &hellip; Continue reading \"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-03T12:08:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference","datePublished":"2025-02-03T12:08:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/"},"wordCount":189,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/","name":"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=","datePublished":"2025-02-03T12:08:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MTU5NCM2NzMxNDQ0IzIwMDc3NTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lifecore-biomedical-to-participate-in-2025-bio-ceo-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lifecore Biomedical to Participate in 2025 BIO CEO &amp; Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/807679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=807679"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/807679\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=807679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=807679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=807679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}